Timber Pharmaceuticals (TMBRQ) has released an update.
Timber Pharmaceuticals has filed for Chapter 11 bankruptcy and cautions investors against relying on their non-GAAP Monthly Operating Reports, which may not provide a solid basis for investment decisions. The company also warns about the high risks associated with trading its securities during the proceedings, as their value might not reflect the potential outcome of the bankruptcy case. Forward-looking statements have been issued but come with the caveat that they are subject to numerous risks and uncertainties that could significantly affect the company’s operations and financial outcomes.
For further insights into TMBRQ stock, check out TipRanks’ Stock Analysis page.
